Centurion Acquisition Corp. ALFUU
Last close
10.91
2026-07-27
Market cap
$132.4M
2026-06-30 share count
52-week range
10.65 - 12.79
Valuation FY2025 figures against the last close
P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS—
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 |
|---|---|---|
| Operating income | -$626.2K | -$467.5K |
| Net income | $11.7M | $7.8M |
Balance sheet
| Fiscal year | FY2025 | FY2024 |
|---|---|---|
| Cash and equivalents | $101.0K | $665.4K |
| Total current assets | $160.9K | $798.8K |
| Total assets | $308.3M | $296.7M |
| Accounts payable | $49.4K | $110.0K |
| Total current liabilities | $60.5K | $125.0K |
| Total liabilities | $13.7M | $13.8M |
| Retained earnings | -$13.6M | -$13.0M |
| Total equity | -$13.6M | -$13.0M |
Cash flow
| Fiscal year | FY2025 | FY2024 |
|---|---|---|
| Operating cash flow | -$564.4K | -$165.2K |
| Investing cash flow | — | -$287.5M |
| Financing cash flow | — | $288.3M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-26-026959.
Others in SIC 6770
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| DMII | Drugs Made In America Acquisition II Corp. | $647.8M | — | — |
| IACO | Idea Acquisition Corp. | $437.1M | — | — |
| KRAQ | KRAKacquisition Corp | $431.6M | — | — |
| TACO | Berto Acquisition Corp. | $393.6M | 36.2x | — |
| ALDF | Aldel Financial II Inc. | $322.7M | — | — |
| ATII | Archimedes Tech SPAC Partners II Co. | $315.1M | — | — |
| FGII | FG Imperii Acquisition Corp. | $289.7M | — | — |
| SOUL | Soulpower Acquisition Corp. | $268.0M | — | — |